Worley holds AGM after growing revenue and maintaining its dividend in FY25

Worley grew FY25 revenue by 4% and held its dividend steady, as it focuses on technology and sustainability-driven growth.

| More on:
Happy shareholders clap and smile as they listen to a company earnings report.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Worley Ltd reported a 4% revenue increase to $12.05 billion, with a steady 50 cent per share dividend and strong sustainability project focus in FY25.
  • The company achieved a 10% rise in underlying EBITA and maintained efficient cash conversion, supported by a $269 million share buy-back.
  • Looking forward, Worley forecasts moderate growth in FY26, plans for strategic adjustments with a focus on technology and AI, and aims for enhanced diversity and sustainability.

The Worley Ltd (ASX: WOR) share price is in focus today as the company holds its annual general meeting (AGM). In FY25, the global professional services company delivered a steady result, including a 4% uplift in revenue to $12.05 billion and maintaining a 50 cent per share dividend, consistent with previous years.

What did Worley report in FY25?

  • Aggregated revenue rose 4% to $12,050 million for FY2025
  • Underlying EBITA increased 10% to $823 million
  • EBITA margin (excluding procurement) improved to 9.2%
  • NPATA reached $475 million
  • Normalized cash conversion stood at 94.9%
  • Final dividend maintained at 50 cents per share, unchanged on prior years

What else do investors need to know?

Worley's diversification—with around 50% of revenue from Energy, 24% from Chemicals, and 26% from Resources—helped soften the impact of challenging global conditions. The company continued its disciplined capital management, spending $269 million so far in an on-market share buy-back program of up to $500 million, reflecting ongoing Board confidence in Worley's financial health.

Sustainability remained core to Worley's strategy, with 60% of aggregated FY2025 revenue linked to sustainability-related projects. The business also delivered major projects across LNG, critical minerals, and renewable fuels, and used technology and AI to improve delivery on complex, global contracts. Leadership changes included a new CFO and board renewals to support the company's next phase of growth.

What did Worley management say?

Chris Ashton, CEO and Managing Director said:

We delivered another strong result in FY2025, in a complex global operating environment marked by economic and political shifts which impacted our customers' investment decisions. Our result reflects the fourth year of consistent growth in revenue, earnings and margin through the disciplined execution of our strategy.

What's next for Worley?

Looking ahead, Worley expects moderate growth for FY2026, with a focus on higher revenue and underlying EBITA. The company's earnings are anticipated to be weighted more towards the second half, reflecting seasonality, targeted restructuring, and continued repositioning for areas of high demand and technology-driven growth. Management has revealed plans to unveil a refreshed strategy, targeting new adjacencies and further AI adoption, at its next Investor Day in May 2026.

Worley says it remains guided by disciplined contract selection, a commitment to sustainability, and ongoing improvement in diversity and inclusion. The leadership team is working to ensure strong foundations for long-term growth while continuing to support customers as the energy, chemicals, and resources landscape evolves.

Worley share price snapshot

Over the past 12 months, Worley shares have declined 4%, underperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 1% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »